Cargando…
Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report
Hereditary hemorrhagic telangiectasia (HHT) is an inherited vascular dysplasia characterized by mucocutaneous telangiectasia and visceral arteriovenous malformations. Hepatic involvement with vascular malformations may lead to portal hypertension, biliary ischemia, and high-output cardiac failure. T...
Autores principales: | Maestraggi, Quentin, Bouattour, Mohamed, Toquet, Ségolène, Jaussaud, Roland, Kianmanesh, Reza, Durand, François, Servettaz, Amélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652814/ https://www.ncbi.nlm.nih.gov/pubmed/26579805 http://dx.doi.org/10.1097/MD.0000000000001966 |
Ejemplares similares
-
Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
por: Ou, George, et al.
Publicado: (2016) -
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019) -
Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab
por: Wee, Jee Wan, et al.
Publicado: (2014) -
Management of Refractory Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia with Bevacizumab
por: Masood, Muaaz, et al.
Publicado: (2021) -
Hereditary Hemorrhagic Telangiectasia
por: Kamath, Nagesh, et al.
Publicado: (2015)